208 related articles for article (PubMed ID: 25855099)
1. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.
Morales DR; Guthrie B; Lipworth BJ; Jackson C; Donnan PT; Santiago VH
Allergy; 2015 Jul; 70(7):828-35. PubMed ID: 25855099
[TBL] [Abstract][Full Text] [Related]
2. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Lee HY; Ye YM; Kim SH; Ban GY; Kim SC; Kim JH; Shin YS; Park HS
Allergy; 2017 Apr; 72(4):616-626. PubMed ID: 27805264
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
Williams AN
Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
Tan JHY; Hsu AAL
Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E
Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
[TBL] [Abstract][Full Text] [Related]
6. Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: A systematic review of the literature and meta-analysis.
Eraso I; Sangiovanni S; Morales EI; Fernández-Trujillo L
PLoS One; 2021; 16(3):e0247871. PubMed ID: 33770090
[TBL] [Abstract][Full Text] [Related]
7. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
[TBL] [Abstract][Full Text] [Related]
8. [The value of aspirin challenge tests in the diagnosis of non-steroidal anti-inflammatory drugs-exacerbated respiratory disease].
Xiao H; Zhang L; Lin H; Xiao YL; Zhang HT; Jia QR; Xu F; Meng J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Aug; 58(8):741-746. PubMed ID: 37550033
[No Abstract] [Full Text] [Related]
9. Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease.
Stevenson DD; White AA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):643-655. PubMed ID: 27712760
[TBL] [Abstract][Full Text] [Related]
10. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
[TBL] [Abstract][Full Text] [Related]
12. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
Park H; Choi Y; Jung CG; Park HS
Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
[TBL] [Abstract][Full Text] [Related]
13. Associations between TMEM196 polymorphisms and NSAID-exacerbated respiratory disease in asthma.
Lee JU; Chang HS; Baek DG; Shin HD; Park CS; Park JS
Pharmacogenet Genomics; 2019 Jun; 29(4):69-75. PubMed ID: 30694883
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and aspirin desensitization in Thai patients with a suggestive history of NSAID-exacerbated respiratory disease.
Wongsa C; Sompornrattanaphan M; Tantilipikorn P; Thongngarm T
Asian Pac J Allergy Immunol; 2022 Sep; 40(3):247-253. PubMed ID: 31677617
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals.
Tuncay G; Damadoglu E; Cihanbeylerden M; Can Bostan O; Kayıkcı H; Özer S; Karakaya G; Kalyoncu AF
J Asthma; 2023 Oct; 60(10):1885-1894. PubMed ID: 36971076
[TBL] [Abstract][Full Text] [Related]
17. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
Williams AN; Simon RA; Woessner KM; Stevenson DD
J Allergy Clin Immunol; 2007 Aug; 120(2):273-7. PubMed ID: 17481713
[TBL] [Abstract][Full Text] [Related]
18. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Berges-Gimeno MP; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
[TBL] [Abstract][Full Text] [Related]
19. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.
Celejewska-Wójcik N; Wójcik K; Ignacak-Popiel M; Ćmiel A; Tyrak K; Gielicz A; Kania A; Nastałek P; Sanak M; Mastalerz L
Allergy; 2020 Apr; 75(4):831-840. PubMed ID: 31803947
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
Klaewsongkram J; Buranapraditkun S; Mongkolpathumrat P; Palapinyo S; Chantaphakul H
Allergy Asthma Immunol Res; 2021 Mar; 13(2):229-244. PubMed ID: 33474858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
